Masuda T, Murakami K, Sugiura K, Sakui S, et al. A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report. Vaccine 2022 Feb 8. pii: S0264-410X(22)00164.
PMID: 35177302